[CADL] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
25-Apr-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -31.54%
YoY- -204.16%
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 1,776 31 31 31 285.50%
PBT -11,095 -5,083 1,596 -10,478 1.92%
Tax 386 -15,735 12 4,504 -55.91%
NP -11,095 10,652 1,596 -10,478 1.92%
Tax Rate - - -0.75% - -
Total Cost 12,871 -10,621 -1,565 10,509 6.99%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin -624.72 34,361.29 5,148.39 -33,800.00 -73.56%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.38 0.37 0.07 -0.56 -12.12%
EPS Diluted -0.38 0.37 0.07 -0.56 -12.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.